Prostate cancer decisions — 2022
1,116 indexed Board decisions in 2022.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: Remanded (sent back)January 2022
The Board has remanded the Veteran's claims for service connection for a cardiovascular disorder and prostate cancer, both potentially related to in-service herbicide exposure. The appeal is being returned to VA for further development of evidence regarding the Veteran's service on ships during his Vietnam-era service.
- Whole decision: DismissedJanuary 2022
The Veteran's appeal for increased disability ratings for prostate cancer has been dismissed due to the Veteran's request to withdraw his appeals.
- Whole decision: Remanded (sent back)January 2022
The Board has remanded the claims for service connection for various conditions, including heart disease, lung disease, prostate cancer, embolic cerebrovascular accident (stroke), and erectile dysfunction, all potentially related to herbicide exposure during service in Thailand. The appellant is requested to provide information about her husband's alleged herbicide exposure while stationed at Takhli, Korat, Ubon, and Udorn RTAFBs.
- Whole decision: Remanded (sent back)January 2022
The Veteran's death was caused by prostate cancer, which the Appellant claims he was exposed to due to herbicide agent exposure at Eglin Air Force Base. The Board has remanded the case for further investigation into the Veteran's exposure and service connection.
- Whole decision: DeniedJanuary 2022
The Board denied service connection for prostate cancer and diabetes mellitus type II, finding that the evidence did not support a link to exposure to herbicide agents during active duty in Korea.
- Whole decision: DeniedJanuary 2022
The Veteran's PTSD is currently rated at 50 percent, which does not meet the criteria for a higher rating.,For the period from June 15, 2018 to March 2, 2020, the Veteran has been granted a TDIU based on his service-connected prostate cancer and other disabilities. The issue of TDIU is moot due to SMC being in place for this period.,Prior to June 15, 2018, the Veteran was found not eligible for a TDIU as he did not meet the schedular criteria at that time.
- Whole decision: GrantedJanuary 2022
The Veteran's claims for service connection for IHD, prostate cancer, and ED are granted due to herbicide exposure during his time in Korea. The Board has ordered the Department of Army to verify the Veteran's claimed exposure.
- Whole decision: GrantedJanuary 2022
The Veteran's service connection for prostate cancer due to herbicide exposure is granted. The Board also remanded the issue of service connection for erectile dysfunction as secondary to prostate cancer.
- Whole decision: Remanded (sent back)January 2022
The Board has remanded the case due to inadequate medical opinions regarding the cause of death and its relation to service-connected conditions.
- Whole decision: DeniedJanuary 2022
The Board denied service connection for prostate cancer as there was no evidence of exposure to herbicide agents during service and the Veteran's service treatment records did not suggest an injury, event, or illness that could lead to prostate cancer.
- Whole decision: Remanded (sent back)January 2022
The Veteran's prostate cancer residuals are rated at 40 percent from December 1, 2016. The Board has determined that the issue of rating reduction for prostate cancer residuals is remanded.
- Whole decision: GrantedJanuary 2022
The Board has restored a 100% rating for prostate cancer, status post radical prostatectomy from May 1, 2016 through October 16, 2019 due to the evidence being at least evenly balanced as to whether there was localized active recurrence and/or metastasis of the cancer.
- Whole decision: GrantedJanuary 2022
The Veteran's tension headaches are granted as secondary to his service-connected tinnitus and unspecified anxiety disorder.,Prostate cancer, kidney condition, and bladder condition are all remanded due to the need for additional medical opinions regarding their relationship to exposure at Camp Lejeune.,Back disability is granted as secondary to service-connected left knee degenerative joint disease (left knee disability).,Right hip disability and left hip disability are both remanded as they may be related to service-connected left knee disability.
- Whole decision: Remanded (sent back)January 2022
The Board has decided to remand the claims of service connection for prostate cancer and entitlement to a TDIU due to inadequate medical opinions regarding exposure to harmful chemicals during active duty.
- Whole decision: DeniedJanuary 2022
The Veteran's initial compensable evaluation for service-connected residuals of skin cancer affecting the left upper forearm and increased rating in excess of 30 percent for residuals of skin cancer affecting the head, face, and neck have been denied.,Service connection for prostate cancer with urinary incontinence and erectile dysfunction secondary to prostate cancer has been remanded.
- Whole decision: GrantedJanuary 2022
The Veteran's prostate cancer, a disease associated with herbicide exposure, is granted for accrued benefits purposes effective April 7, 2004.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.